Specifically, our in vitro experiments show that most RNF43 mutations detected in MSS tumors of responding patients have a loss-of-function effect, which contrasts with RNF43 mutations described in MSI tumors, where the protein retains its function26. The gene discussed is RNF43; the disease is Marinesco-Sjogren syndrome.